Inactive Instrument

AveXis Inc Stock

Equities

US05366U1007

Biotechnology & Medical Research

Chart AveXis Inc

Duration

Period

Style

Latest news about AveXis Inc

Novartis : top lawyer exits over Trump attorney deal 'mistake'	18-05-16	RE
Novartis : top lawyer exits over Trump attorney deal 'mistake'	18-05-16	RE
Novartis : CEO feels heat on U.S. generics, Cosentyx drop	18-04-19	RE
GlaxoSmithKline : GSK slims portfolio with sale of rare disease gene therapy drugs	18-04-12	RE
GlaxoSmithKline : UK gene therapy firm Orchard plans stock offer after GSK deal	18-04-12	RE
Takeda sounds out banks for loans as it moves towards Shire bid: sources	18-04-12	RE
Takeda sounds out banks for loans as it moves towards Shire bid: sources	18-04-12	RE
Takeda Pharmaceutical : sounds out banks for loans as it moves towards Shire bid - sources	18-04-12	RE
Wall Street rises but pares gains late after report of FBI raid	18-04-09	RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal	18-04-09	RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal	18-04-09	RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal	18-04-09	RE
European shares rise as trade optimism spreads	18-04-09	RE
AveXis : Novartis AG to buy AveXis Inc for $8.7 billion	18-04-09	RE

Press releases AveXis Inc

AveXis Reports First Quarter 2018 Financial and Operating Results	18-05-03	GL
AveXis Provides Update on Proposed Acquisition by Novartis AG	18-05-01	GL
AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3	18-04-25	GL
AveXis : RM LAW Announces Investigation of AveXis, Inc.	18-04-19	PR
AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology	18-04-19	GL

More press releases

News in other languages on AveXis Inc

Les valeurs à suivre aujourd'hui à Wall Street - Mercredi 18 avril 2018	18-04-18
AVEXIS : l'offre de NOVARTIS s'ouvre aujourd'hui jusqu'au 14 mai	18-04-18
REPETE : Les grandes biotech ont les moyens de redorer leur blason à Wall Street - Plus USA	18-04-16
REPETE : Les grandes biotech ont les moyens de redorer leur blason à Wall Street -- Plus USA	18-04-16
Alexion Pharmaceuticals : acquiert la biotech suédoise Wilson Therapeutics	18-04-11

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-0.49%	103B
REGENERON PHARMACEUTICALS, INC.	+3.31%	96.73B
ARGENX SE	+1.66%	21.31B
BIONTECH SE	-16.16%	21.21B
GENMAB A/S	-6.82%	18.79B
WUXI APPTEC CO., LTD.	-41.41%	16.37B
BEIGENE, LTD.	-22.87%	13.68B
NEUROCRINE BIOSCIENCES, INC.	+6.32%	13.44B
SAREPTA THERAPEUTICS, INC.	+21.46%	10.98B

Bio Therapeutic Drugs

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer